RenovoRx, Inc. ("RenovoRx" or the "Company") , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared delivery system, today ...

Tinnitus affects up to 43% of people depending on definitions and populations studied. This phantom perception of sound can ...

Ractigen Therapeutics, a clinical-stage Pharmaceutical company dedicated to developing RNA-based innovative therapies, today announced the successful dosing of the first patient in the Phase I ...

A new study highlights a groundbreaking development for chronic low back pain caused by degenerative disc disease (DDD).

Exercise interventions may help manage chemotherapy-induced peripheral neuropathy (CIPN) in patients with ovarian cancer ...

ASPIRE Level 1 Outcomes Published Demonstrating Superior Stone Clearance with the SURE Procedure using the CVAC System vs. Standard Ureteroscopy ...

A recently published, comprehensive systematic review and meta-analysis has added to the growing body of evidence showing that beef can be enjoyed in a heart-healthy diet.

A recently published, comprehensive systematic review and meta-analysis has added to the growing body of evidence showing ...

Cognitive and behavioral techniques can improve physical function and overall well-being in patients with long COVID.

The ISCHEMIA Trial randomly assigned patients with ischemic heart disease to an invasive treatment strategy centered on revascularization with a control group assigned non-invasive medical therapy. As ...

However, given the challenges with conducting long-term randomized controlled trials (RCTs), guidance is often based on observational evidence ... “Given the disparity of products in the ‘red meat’ ...

Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that an abstract highlighting final clinical and biomarker data from its Phase 2 clinical trial evaluating casdozokitug (casdozo), a ...